Major Bleeding in AF Patients Treated With Apixaban or Warfarin
Major bleeding during oral anti-coagulant treatment in patient with AF is associated with a substantially increased subsequent risk of both death and of thrombotic events such as ischaemic stroke or MI. Our results underscore the importance of prevention of bleeding in anti-coagulated patients as well as highlight the medical complexities and treatment decision challenges among individuals with bleeding.
Conclusion
Major bleeding during oral anti-coagulant treatment in patient with AF is associated with a substantially increased subsequent risk of both death and of thrombotic events such as ischaemic stroke or MI. Our results underscore the importance of prevention of bleeding in anti-coagulated patients as well as highlight the medical complexities and treatment decision challenges among individuals with bleeding.
SHARE
